November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Breaking Science in Gastrointestinal Cancers with David Tougeron – ESMO
Jul 31, 2024, 07:32

Breaking Science in Gastrointestinal Cancers with David Tougeron – ESMO

ESMO shared on LinkedIn:

“For ESMO members: Breaking Science in Gastrointestinal Cancers.
David Tougeron discusses Pembrolizumab combo with XELOX and bevacizumab for pMMR/MSS mCRC and high immune infiltrate.
Discover this video and more in the series on OncologyPRO now.”

Pembrolizumab combo with XELOX and bev for pMMR/MSS mCRC and high immune infiltrate

Speaker: David Tougeron

Abstract discussed: Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate.

Breaking Science

Source: ESMO/LinkedIn